Log In
BCIQ
Print this Print this
 

Mentax (formerly KP363)

Also known as: butenafine

  Manage Alerts
Collapse Summary General Information
Company Mylan N.V.
DescriptionSynthetic antifungal agent
Molecular Target Not available
Mechanism of ActionCell membrane destabilization
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$40,100.0M

$20,050.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/21/2015

$40,100.0M

$20,050.0M

0

Get a free BioCentury trial today